61 – 70 of 329
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Correlation to FVIII : C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
(
- Contribution to journal › Article
-
Mark
Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy : The Malmö experience
(
- Contribution to journal › Article
-
Mark
Thrombin generation assays (TGAs)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
(
- Contribution to journal › Article
- 2016
-
Mark
ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy.
(
- Contribution to journal › Article
-
Mark
Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.
(
- Contribution to journal › Article
-
Mark
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
2016) In Haemophilia(
- Contribution to journal › Article
-
Mark
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.
(
- Contribution to journal › Article
-
Mark
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands
(
- Contribution to journal › Article